Biotech Updates

Research Shows Slow Development of Drugs for Neglected Diseases

November 6, 2013

Of the 850 new drugs and vaccines approved over the past decade, only 37 were for neglected diseases such as malaria, tuberculosis, chagas, sleeping sickness, and other diseases of poverty, according to a study published in The Lancet Global Health. Dr. Belen Pedrique and other authors called this as a "fatal imbalance" in the research and development of treatments for the world's poorest patients. Furthermore, there is only a few  on going clinical trials on drugs for neglected diseases. They said that this can be attributed to the little financial incentive in investing in R&D of finding treatments for neglected diseases.

Read the original article at and the research article at